Bayer Consumer Health licenses MOB-015

14 February 2019 - Deborah Wilkes

Premium

Bayer Consumer Health has signed an exclusive European licensing agreement for MOB-015, Moberg Pharma's novel topical terbinafine formulation for treating nail fungus.

Click tags below for more information on topics:

Bayer Consumer Health

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: